Skip to main content
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
FDA Oncology Update
Recent Cancer Drugs Approved by the FDA
Read More
Recent Cancer Drugs Approved by the FDA
Read More
Recent Cancer Drugs Approved by the FDA
Read More
Recent Cancer Drugs Approved by the FDA
Read More
Nivolumab in Combination with Ipilimumab
Read More
Pembrolizumab FDA Approved in Patients with Advanced Lung Cancer
Read More
FDA Approves New Therapy for Certain Types of Advanced Soft Tissue Sarcoma
Read More
FDA Approves Yervoy to Reduce the Risk of Melanoma Returning After Surgery
Read More
FDA Approves New Treatment for Advanced Pancreatic Cancer
Read More
FDA Approves First-of-Its-Kind Product for the Treatment of Melanoma
Read More
1
2
3
4
Page 1 of 26
Results 1 - 10 of 253